Literature DB >> 11898479

Radiation-induced neurocognitive decline: the risks and benefits of reducing the amount of whole-brain irradiation.

Roger J Packer.   

Abstract

Mesh：

Year:  2002        PMID： 11898479     DOI： 10.1007/s11910-002-0021-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  7 in total

1.  Medulloblastoma in childhood: progressive intellectual deterioration.

Authors:  E Hoppe-Hirsch; D Renier; A Lellouch-Tubiana; C Sainte-Rose; A Pierre-Kahn; J F Hirsch
Journal:  Childs Nerv Syst       Date:  1990-03       Impact factor: 1.475

2.  Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.

Authors:  R K Mulhern; J L Kepner; P R Thomas; F D Armstrong; H S Friedman; L E Kun
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

3.  Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.

Authors:  M D Ris; R Packer; J Goldwein; D Jones-Wallace; J M Boyett
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

4.  Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

Authors:  R J Packer; J Goldwein; H S Nicholson; L G Vezina; J C Allen; M D Ris; K Muraszko; L B Rorke; W M Wara; B H Cohen; J M Boyett
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

5.  Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy.

Authors:  J Radcliffe; R J Packer; T E Atkins; G R Bunin; L Schut; J W Goldwein; L N Sutton
Journal:  Ann Neurol       Date:  1992-10       Impact factor: 10.422

6.  Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score.

Authors:  J H Silber; J Radcliffe; V Peckham; G Perilongo; P Kishnani; M Fridman; J W Goldwein; A T Meadows
Journal:  J Clin Oncol       Date:  1992-09       Impact factor: 44.544

7.  Quality of life in children with primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa.

Authors:  R J Packer; R Sposto; T E Atkins; L N Sutton; D A Bruce; K R Siegel; L B Rorke; P A Littman; L Schut
Journal:  Pediatr Neurosci       Date:  1987
  7 in total
  4 in total

1.  Dmp53 protects the Drosophila retina during a developmentally regulated DNA damage response.

Authors:  Omar W Jassim; Jill L Fink; Ross L Cagan
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 2.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 3.  Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.

Authors:  Sharon M Castellino; Nicole J Ullrich; Megan J Whelen; Beverly J Lange
Journal:  J Natl Cancer Inst       Date:  2014-07-30       Impact factor: 13.506

4.  Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma.

Authors:  Theresa A Lawrie; David Gillespie; Therese Dowswell; Jonathan Evans; Sara Erridge; Luke Vale; Ashleigh Kernohan; Robin Grant
Journal:  Cochrane Database Syst Rev       Date:  2019-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.